Medscape4d
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...
HealthDay on MSN1d
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...
Hosted on MSN2d
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
TUESDAY, Nov. 12, 2024 (HealthDay News) -- For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) ...
Monthly Prescribing Reference17d
Increases in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes Seen in Last Decade
“Prospective studies on the efficacy and safety of GLP-1 RAs or SGLT2 inhibitors in the T1D population are needed,” the authors write. “Before such evidence becomes available, caution should ...
Renal & Urology News10d
2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes
“Prospective studies on the efficacy and safety of GLP-1 RAs or SGLT2 inhibitors in the T1D population are needed,” the authors write. “Before such evidence becomes available, caution should ...